Deutsch Intern
  • none
  • none

Another international accolade for Hermann Einsele

11/17/2026

The UK Myeloma Society honours the Würzburg-based haematologist Hermann Einsele for his outstanding contributions to the research and treatment of multiple myeloma.

none
Rachel Hall, Chair of the UK Myeloma College, congratulates Hermann Einsele on his fellowship. (Image: UK Myeloma College)

Another international honour for Professor Hermann Einsele: on 11 November 2026, the Director of Medical Clinic and Polyclinic II at Würzburg University Hospital (UKW) was honoured in London by the UK Myeloma Society as a ‘Fellow of the College of Myeloma’.

Through admission to the College of Myeloma, the British professional society recognises individuals who have made outstanding contributions to the research, treatment and care of people with multiple myeloma. The fellowship is awarded for exceptional contributions to clinical practice, clinical and translational research, medical education and the advocacy of patients’ interests.

Founded in 2019, the College brings together internationally renowned experts from the fields of medicine, science and the healthcare professions. Among other things, it advises the UK Myeloma Society on the development of scientific and clinical strategies, supports the design of clinical trials and promotes the next generation of scientists.

Hermann Einsele: “I am delighted to receive this special international recognition. For me, it is also a tribute to the many people with whom I work in Würzburg and around the world. The advances in the treatment of multiple myeloma are the result of joint efforts, intensive international collaboration and a keen scientific curiosity. It is particularly rewarding when this leads to new treatment options and tangible improvements for patients.”

International recognition for myeloma research in Würzburg

Hermann Einsele is one of the world’s leading experts in the field of multiple myeloma, a malignant disease of the bone marrow. His research focuses, amongst other things, on CAR-T cell therapies, bispecific antibodies, adoptive immunotherapies and stem cell transplants. Through his scientific work, he has helped drive forward important developments in the treatment of the disease and contributed to bringing new immunotherapeutic approaches into clinical practice.

The award in London is the latest in a series of international honours: as recently as June 2026, Einsele received the Robert A. Kyle Lifetime Achievement Award from the International Myeloma Foundation in Stockholm. A few days earlier, he had been awarded the Francesca Cassinelli Award 2025 in Italy.

By Press Office University Hospital / translated with deepL-AI

Back